Post-approval studies (Phase 4)Study completedNCT00178828What this trial is testingDynamic Measures of Neurochemistry in Mood DisordersWho this might be right forDepression Vanderbilt University Medical Center 42
Not applicableStudy completedNCT00006172What this trial is testingClinical Trials of Two Non-drug Treatments for Chronic DepressionWho this might be right forMood DisordersDepressive DisordersDepression+1 more New York State Psychiatric Institute 32
Not applicableUnknownNCT02438072What this trial is testingDrug Metabolism and AntidepressantWho this might be right forDepression University Hospital, Geneva 100
Testing effectiveness (Phase 2)Study completedNCT00025792What this trial is testingClinical Trial of Pramipexole in Bipolar DepressionWho this might be right forBipolar Disorder National Institute of Mental Health (NIMH) 200
Testing effectiveness (Phase 2)Study completedNCT00822744What this trial is testingAn Eight-week Study of SSR411298 as Treatment for Major Depressive Disorder in Elderly PatientsWho this might be right forMajor Depressive Disorder Sanofi 527
Not applicableWithdrawnNCT02223299What this trial is testingPilot Study: Combining Nutritional Supplements With Standard Antidepressant to Treat Depression.Who this might be right forDepression John D. Dingell VA Medical Center
Not applicableNot Yet RecruitingNCT07601477What this trial is testingAssessing the Impact of the Personalized Medicine Clinic on Mental Health OutcomesWho this might be right forMental HealthDepressive DisorderPharmacogenetic Testing+1 more London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 200
Testing effectiveness (Phase 2)Study completedNCT01518634What this trial is testingImipramine Treatment for Patients With Multi-organ Bodily Distress SyndromeWho this might be right forSomatisation DisorderSomatoform Disorders University of Aarhus 138
Not applicableUnknownNCT01228357What this trial is testingPredict Antidepressant Responsiveness Using PharmacogenomicsWho this might be right forDepressionDepressive Symptoms Samsung Medical Center 1,000
Testing effectiveness (Phase 2)Ended earlyNCT01119430What this trial is testingFluoxetine Versus Fluoxetine Plus DU125530 in Major Depressive DisorderWho this might be right forMajor Depression Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 50
Early research (Phase 1)Study completedNCT00946764What this trial is testingTo Demonstrate the Relative Bioavailability of Sandoz Inc. and Tyco Healthcare (Tofranil) 50 mg Imipramine Hydrochloride Tablets In Healthy Adults Volunteers Under Fasting ConditionsWho this might be right forDepression Sandoz 48
Not applicableStudy completedNCT00381199What this trial is testingNabilone Versus Amitriptyline in Improving Quality of Sleep in Patients With FibromyalgiaWho this might be right forFibromyalgiaSleep Initiation and Maintenance Disorders McGill University Health Centre/Research Institute of the McGill University Health Centre 32
Not applicableEnded earlyNCT00622947What this trial is testingThe Antidepressant Effect of Right Temporal Low Frequency rTMS Compared to ShamWho this might be right forDepressive Disorder University of Aarhus 10
Testing effectiveness (Phase 2)Ended earlyNCT02049385What this trial is testingDoes Enhanced Glutamate Transporter Function Produce Antidepressant Effects in People With Major Depression?Who this might be right forDepression National Institute of Mental Health (NIMH) 10
Not applicableStudy completedNCT04069819What this trial is testingThe Phosphodiesterase-3 Inhibitor Cilostazol as an Adjunctive to Antidepressants in Patients With Major Depressive Disorder.Who this might be right forMajor Depressive Disorder Sadat City University 80
Early research (Phase 1)Study completedNCT00883155What this trial is testingTo Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets Under Fasting ConditionsWho this might be right forHealthy Sandoz 36
Testing effectiveness (Phase 2)Study completedNCT01234558What this trial is testingSingle IV Dose of GLYX-13 in Patients With Treatment-Resistant DepressionWho this might be right forMajor Depressive Disorder Naurex, Inc, an affiliate of Allergan plc 115
Testing effectiveness (Phase 2)Study completedNCT00733980What this trial is testingThe Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive DisorderWho this might be right forDepressive Disorder, Major GlaxoSmithKline 150
Testing effectiveness (Phase 2)Study completedNCT00976560What this trial is testingClinical Study to Test a New Drug to Treat Major DepressionWho this might be right forDepressive Disorder, Major GlaxoSmithKline 128
Not applicableUnknownNCT05422417What this trial is testingDorsomedial Prefrontal Neuromodulation in Treatment-resistant DepressionWho this might be right forTreatment-resistant DepressionMajor Depressive Disorder Taipei Veterans General Hospital, Taiwan 75